Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    New cancer treatment offers hope to patients out of options

    August 24th, 2022

    By Andrew Gregory Health editor

    The Guardian
    2 days ago

    A new cancer treatment can stop the disease advancing in patients who are resistant to immunotherapy, doctors have discovered.

    Immunotherapy uses the immune system to target and kill cancer…

    Read Article

    Direct anti-cancer effect of oncostatin M on chondrosarcoma

    August 17th, 2022

    Emmanuelle David,Pierre Guihard,Bénédicte Brounais,Anne Riet,Céline Charrier,Séverine Battaglia,François Gouin,Stéphanie Ponsolle,Ronan Le Bot,Carl D. Richards … See all authors

    First published: 15 November…

    Read Article

    Jaimie Elliott is featured in Brighter Magazine

    July 30th, 2022

    Jamie Elliott a Chondrosarcoma Warrior extraordinaire. She is featured in this months Brighter Magazine for women who live their life with cancer. Jamie shows her spirit and how she overcomes obstacles by wining Pickleball Championships. Jamie is a…

    Read Article

    23andMe Phase 1 Trial is an Immunotherapy for treating advanced solid tumors


    A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.

    Read Article

    Happy Heavenly 50th Birthday to Stanley Cornejo

    June 23rd, 2022

    Today is Stanley Tono Cornejo’s 50th Birthday. Please send good wishes and prayers to his family.

    Read Article

    Where to enroll in the Randomized, Placebo-Controlled, Phase 2 Trial,of INBRX-109 in Unresectable or Metastatic,Conventional Chondrosarcoma

    June 17th, 2022

    Inhibrx submitted the attached poster at the American Society of Clinical Oncology ASCO Conference last month. It addresses the Phase 2 study and the locations where they plan to have their our pivotal study for the medication INBRX-109. The best…

    Read Article

    Comprehensive Fact Sheet on Chondrosarcoma from the Bone Cancer Research Trust

    June 14th, 2022

    The Bone Cancer Research Trust has a 12 page comprehensive fact sheet on Chondrosarcoma. It defines Chondrosarcoma, who it affects, the symptoms, sub-types, causes and risk factors, diagnosing, treatment, follow-up, rehabilitation and support.

    For…

    Read Article

    New Research Findings on Mesenchymal Chondrosarcoma of the Head and Neck with HEY1::NCOA2 Fusion

    June 9th, 2022

    Mesenchymal Chondrosarcoma of the Head and Neck with HEY1::NCOA2 Fusion: a Clinicopathologic and Molecular Study of 13 Cases with Emphasis on Diagnostic Pitfalls Bin Xu 1, Lisa M Rooper 2, Josephine K Dermawan 1, Yanming Zhang 1, Albert J H…

    Read Article

    Videos for Virtual Dialogue 4

    May 16th, 2022

    The Chondrosarcoma Foundation, Inc. hosted their fourth International Virtual Dialogue on April 30, 2022; featuring the prominent experts to address new innovations, findings and technologies to improve the treatment of Chondrosarcoma. The videos…

    Read Article

    Chondrosarcoma Foundation Enters Third Year, Marks Progress

    May 10th, 2022

    BOWIE, Maryland, May 10—The Chondrosarcoma (CS) Foundation will commemorate its second anniversary by continuing to educate the public about this rare bone cancer and advocate for patients fighting the disease.

    On May 14, 2020, the CS Foundation…

    Read Article
    Skip to content